Publication:

Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis

Loading...
Thumbnail Image

Date

2017

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

American Association for the Advancement of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Cokol, Murat, Nurdan Kuru, Ece Bicak, Jonah Larkins-Ford, and Bree B. Aldridge. 2017. “Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis.” Science Advances 3 (10): e1701881. doi:10.1126/sciadv.1701881. http://dx.doi.org/10.1126/sciadv.1701881.

Abstract

Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited because of the lack of both efficient measurement methods and theoretical framework for analysis and interpretation. We developed an efficient experimental sampling and scoring method [diagonal measurement of n-way drug interactions (DiaMOND)] to measure drug interactions for combinations of any number of drugs. DiaMOND provides an efficient alternative to checkerboard assays, which are commonly used to measure drug interactions. We established a geometric framework to factorize high-order drug interactions into lower-order components, thereby establishing a road map of how to use lower-order measurements to predict high-order interactions. Our framework is a generalized Loewe additivity model for high-order drug interactions. Using DiaMOND, we identified and analyzed synergistic and antagonistic antibiotic combinations against Mycobacterium tuberculosis. Efficient measurement and factorization of high-order drug interactions by DiaMOND are broadly applicable to other cell types and disease models.

Description

Research Data

Keywords

SciAdv r-articles, Health and Medicine, Drug Interactions

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories